Eupraxia Pharmaceuticals, Inc. (TSE:EPRX) has released an update.
Eupraxia Pharmaceuticals Inc., a biotech firm specializing in extended-release drug delivery technologies, is set to present at the Bloom Burton & Co. Healthcare Investor Conference in Toronto. Their CEO, Dr. James Helliwell, will showcase the company’s advances, including their proprietary Diffusphere™ technology, and discuss recent successful Phase 2b clinical trial results for osteoarthritis knee pain treatment.
For further insights into TSE:EPRX stock, check out TipRanks’ Stock Analysis page.
